A detailed history of Steward Partners Investment Advisory, LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 56,585 shares of ETNB stock, worth $564,152. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56,585
Previous 36,110 56.7%
Holding current value
$564,152
Previous $420,000 7.86%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$7.31 - $10.9 $149,672 - $223,177
20,475 Added 56.7%
56,585 $453,000
Q1 2024

May 15, 2024

BUY
$8.13 - $13.77 $293,574 - $497,234
36,110 New
36,110 $420,000

Others Institutions Holding ETNB

About 89bio, Inc.


  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $463M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.